Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRITIC
2010-023030-23Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection (2 arms), sponsored by University of Nottingham. Primary endpoint: Renal elimination rate constant of tobramycin. Started Nov 2010; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2010-023030-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023030-23.